# 常温机灌注市场 > 常温机灌注市场研究报告按应用（器官保存、器官移植、研发）、按最终用户（医院、研究实验室、器官采购组织）、按产品类型（便携式常温机、固定式常温机）、按技术（机械循环技术、氧合技术、监测技术）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 18.07% - **2024:** $ 1.63 Billion - **2025:** $ 1.92 Billion - **2035:** $ 10.13 Billion - **Key Players:** Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifePort (US), Waters Medical Systems (US), Bridge to Life (GB), Tissue Regenix (GB), NantKwest (US) **Report ID:** MRFR/HC/38164-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Kinjoll Dey · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/normothermic-machine-perfusion-market-40190 --- ## Market Summary ## **Normothermic Machine Perfusion Market Overview** As per MRFR analysis, the Normothermic Machine Perfusion Market Size was estimated at 1.63 (USD Billion) in 2024. The Normothermic Machine Perfusion Market Industry is expected to grow from 1.92 (USD Billion) in 2025 to 8.58 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 18.07% during the forecast period (2025 - 2034). ### **Key Normothermic Machine Perfusion Market Trends Highlighted** A number of important variables are propelling the notable expansion of the global normothermic machine perfusion market. The growing need for organ transplants, which has brought attention to the need for sophisticated preservation methods, is one of the primary motivators. Better results for transplanted organs are achieved by normothermic machine perfusion, making it a desirable choice for medical facilities and transplant centers. Furthermore, the use of these devices is rising as a result of technological developments and a better understanding of organ preservation. The market's growth is further aided by the emphasis on patient safety and raising transplant success rates. Opportunities in the normothermic machine perfusion space can be captured by innovating new technologies that enhance the perfusion process. Developing more compact and user-friendly machines can cater to smaller facilities that may not have the resources for larger systems. Additionally, increasing awareness about the benefits of machine perfusion among healthcare providers and patients can lead to greater acceptance and demand. Collaborations between manufacturers and healthcare institutions may also open new pathways for market growth, especially in emerging economies where the need for organ transplantation is rising. Recent trends in the market indicate a shift towards automated solutions that minimize human error and increase efficiency during organ preservation. There is a growing emphasis on the integration of software applications that can monitor and manage the perfusion process in real time, enhancing the quality of care provided to transplanted organs. Moreover, the focus on personalized medicine is influencing product development as healthcare providers seek tailored solutions that meet individual patient needs. Overall, the landscape of the Global Normothermic Machine Perfusion Market is evolving rapidly as it adapts to emerging technologies, changing regulations, and increasing demand for organ transplants. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Normothermic Machine Perfusion Market Drivers** ### Increasing Demand for Organ Transplants The growing incidence of chronic diseases and organ failures has led to a significant rise in the demand for organ transplants. As populations age and lifestyle-related health issues become more prevalent, the need for efficient preservation and transportation of organs is paramount. The Global Normothermic Machine Perfusion Market addresses these needs by offering advanced techniques that improve the viability of organs outside the human body, ensuring that they remain in optimal condition until transplantation. This is crucial for both donors and recipients, as it enhances the success rates of transplant surgeries. Moreover, with advancements in medical technology and practices, it's clear that many healthcare providers are increasingly adopting normothermic machine perfusion as a standard procedure for organ recovery. As healthcare systems strive to improve outcomes and increase the number of successful transplants, the Global Normothermic Machine Perfusion Market is positioned for robust growth. The combination of rising awareness about the benefits of machine perfusion, coupled with evolving regulations favoring organ allocation and transplantation, further underlines the importance of this market driver in the coming years, propelling the Global Normothermic Machine Perfusion Market forward. ### Technological Advancements in Machine Perfusion Techniques Technological innovation is a primary driver for the growth of the Global Normothermic Machine Perfusion Market. Newer machines and methodologies are being developed that allow for better preservation of organs, leading to improved surgical outcomes. Innovations such as enhanced monitoring systems and automated processes have made these machines more user-friendly and effective. The integration of artificial intelligence and machine learning into these systems can further augment their capabilities, predicting which organs are at risk and optimizing perfusion techniques to counteract this. As these advanced technologies become more prevalent, healthcare providers are likely to invest more heavily in normothermic machine perfusion equipment and training, thereby increasing the market's growth trajectory. ### Growing Awareness and Acceptance of Machine Perfusion Among Healthcare Professionals The healthcare industry's increasing recognition of the benefits of normothermic machine perfusion has propelled the market forward. With more medical professionals understanding the efficacy and advantages of these devices, the acceptance of machine perfusion as a standard procedure has grown. Educational initiatives aimed at raising awareness about the effectiveness of machine perfusion techniques are contributing to this trend. This growing acceptance not only facilitates the expanded use of these technologies in transplant procedures but also encourages further investment and research into the Global Normothermic Machine Perfusion Market. As healthcare practitioners increasingly advocate for these advanced techniques, the market is expected to see substantial growth, ultimately benefiting the patients in need of transplants. ## **Normothermic Machine Perfusion Market Segment Insights** ### **Normothermic Machine Perfusion Market Application Insights** The Application segment of the Global Normothermic Machine Perfusion Market showcased significant growth and increasing relevance in various medical fields, particularly in organ preservation, organ transplantation, and research and development. Within this segment, organ preservation held a pivotal position, with a valuation of 0.45 USD Billion in 2023, projected to reach 2.0 USD Billion by 2032, demonstrating its majority holding due to the critical need for maintaining the health of organs prior to transplantation.  The importance of this application lies in its ability to extend the viability of organs, reducing the risk of damage and improving transplant success rates. Meanwhile, organ transplantation, valued at 0.55 USD Billion in 2023 and expected to grow to 2.4 USD Billion by the end of the forecast period, indicated its significant impact in improving patient outcomes through innovative preservation techniques. Research and development, though the smallest component within this segment at 0.17 USD Billion in 2023 and projected to reach 0.8 USD Billion by 2032, played a vital role in advancing perfusion technologies and methodologies, thus fostering innovation and enhancing medical practices. The dynamics of the Global Normothermic Machine Perfusion Market statistics presented a landscape of opportunity driven by technological advancements and an increased emphasis on organ preservation strategies. Challenges, such as regulatory hurdles and the need for further research, persist in the industry. However, the growth drivers in this space included rising organ transplant rates and an increasing population in need of transplantable organs. It is evident that each application within the Global Normothermic Machine Perfusion Market segmentation contributes to the overarching objective of improving transplant success rates and patient outcomes, showcasing the robust and interlinked nature of the industry. This segment illustrated the importance of continuous evolution in medical technology and practices, thereby reaffirming its position as an integral part of modern healthcare solutions. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Normothermic Machine Perfusion Market End User Insights** The Global Normothermic Machine Perfusion Market shows robust growth potential within the End User segment, which includes Hospitals, Research Laboratories, and Organ Procurement Organizations. Hospitals play a vital role in utilizing normothermic machine perfusion technology, providing advanced treatment options for organ preservation and transplant procedures. Research Laboratories contribute to the market's innovation through ongoing studies and the development of new techniques, thereby enhancing the effectiveness of organ transplantation processes. Organ Procurement Organizations are significant players, as they are essential for the sourcing and transportation of organs, ensuring that the procedures are timely and efficient. With a projected rise in organ transplants worldwide and increasing awareness regarding the benefits of normothermic machine perfusion, the market is anticipated to see a substantial boost. The Global Normothermic Machine Perfusion Market segmentation highlights how Hospitals dominate the market owing to their critical role in patient care and transplantation success rates. Research Laboratories, while smaller in number, act as incubators for groundbreaking advancements that can profoundly impact clinical applications. Organ Procurement Organizations are integral to streamlining operations that ensure that quality organs reach hospitals swiftly, ultimately facilitating better patient outcomes. Overall, these interconnected segments drive the market's growth and adaptation in a rapidly evolving healthcare environment. ### **Normothermic Machine Perfusion Market Product Type Insights** The Global Normothermic Machine Perfusion Market is currently valued at 1.17 billion USD and is projected to experience significant growth in the coming years. This market is segmented primarily into Portable Normothermic Machines and Stationary Normothermic Machines, each playing a crucial role in the efficacy of organ preservation during transplantation. The Portable Normothermic Machine is gaining traction due to its mobility and adaptability, making it suitable for various medical settings. This ensures that organs are preserved effectively while being transported. Conversely, the Stationary Normothermic Machine tends to dominate in clinical settings where constant, reliable performance is essential. The increasing frequency of organ transplants and the need for improved preservation methods are key factors driving growth within these segments. With rapid technological advancements and rising awareness of the advantages of normothermic machine perfusion, the Global Normothermic Machine Perfusion Market is set for robust expansion, driven by innovations in both portable and stationary equipment. Trends such as improved device ergonomics and workflow efficiency are also expected to contribute to market growth as they enhance user experience and ensure better patient outcomes. ### **Normothermic Machine Perfusion Market Technology Insights** The Global Normothermic Machine Perfusion Market shows promising growth driven by technological advancements in the field. The market is characterized by various technologies that enhance organ preservation and transplantation outcomes. Mechanical Circulation Technology is significant due to its ability to effectively circulate fluids, ensuring oxygen delivery to vital organs, while Oxygenation Technology plays a crucial role in maintaining appropriate gas exchange, a vital factor for successful organ preservation. Monitoring Technology is also critical, as it allows real-time tracking of parameters, providing essential data for clinicians to make timely decisions during the perfusion process. Together, these technologies contribute to the overall efficiency and success of normothermic machine perfusion, elevating the standards of care within the Global Normothermic Machine Perfusion Market. The growing emphasis on innovation and patient outcomes presents substantial opportunities for market players, making it a dynamic segment within the industry. As the market continues to evolve, understanding the interplay between these technologies will be vital for stakeholders aiming to navigate the expanding landscape effectively. ### **Normothermic Machine Perfusion Market Regional Insights** North America commanded a majority holding in this market, valued at 0.45 USD Billion in 2023 and expected to grow to 2.05 USD Billion by 2032, primarily due to its advanced healthcare infrastructure and rising demand for organ transplantation. Europe followed closely, valued at 0.35 USD Billion and anticipated to reach 1.6 USD Billion, driven by established regulatory frameworks and increasing healthcare investments. The Asia-Pacific (APAC) region is also experiencing robust growth, with a market valuation of 0.25 USD Billion in 2023, expected to rise to 1.2 USD Billion, fueled by expanding healthcare facilities and a growing population. South America and Middle East  Africa (MEA) represented smaller yet emerging markets, valued at 0.05 USD Billion and 0.07 USD Billion, respectively, in 2023. These regions are beginning to see improvements in healthcare access, propelling their involvement in the Global Normothermic Machine Perfusion Market. The regional segmentation showcases varying growth drivers, with North America and Europe leading due to technological advancements, while APAC presents significant opportunities attributed to increasing investment in healthcare infrastructure. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Normothermic Machine Perfusion Market Key Players and Competitive Insights** The Global Normothermic Machine Perfusion Market is witnessing significant evolution, driven by advancements in medical technology and increasing demand for organ transplantation. The competitive landscape is marked by a diverse array of players, all pursuing innovative solutions to improve organ preservation and enhance surgical outcomes. Key competitors are focusing on research and development efforts to bring advanced perfusion technologies to market, ensuring that their offerings remain at the forefront of efficiency and efficacy in organ transplantation. As the market continues to expand, the emphasis is not only on product innovation but also on forging strategic partnerships and collaborations to enhance market presence and reach more healthcare providers globally. SurgiCor has positioned itself as a notable player in the Global Normothermic Machine Perfusion Market, leveraging its strong technological capabilities and commitment to quality. The company is known for its robust product portfolio that aims to provide optimal organ preservation solutions, seamlessly integrating with surgical practices. Its emphasis on customer relationships and understanding clinician needs has enabled SurgiCor to foster loyalty among healthcare providers. Strong research and development initiatives have allowed SurgiCor to stay ahead of the curve, consistently introducing cutting-edge solutions that enhance the efficacy of organ perfusion. The firm's dedicated focus on regulatory compliance and clinical validation further strengthens its brand reputation in the market. InnovaHealth operates with a distinctive approach in the Global Normothermic Machine Perfusion Market, aiming to innovate organ preservation technologies that cater to specific clinical needs. The company is recognized for its agile development strategies and responsiveness to market demands, which enables it to quickly adapt its product offerings. InnovaHealth's strengths lie in its emphasis on collaboration with key stakeholders, including hospitals and transplantation centers, ensuring its solutions are not only effective but also meet the practical needs of medical professionals. The firm has adopted a customer-centric approach, focusing on delivering superior value through tailored solutions that enhance organ viability. As a result, InnovaHealth has been able to establish a significant presence in the market, characterized by strategic partnerships that bolster its reputation and expand its influence in the realm of organ transplantation. ### **Key Companies in the Normothermic Machine Perfusion Market Include** ## **Normothermic Machine Perfusion Market Developments** In the Global Normothermic Machine Perfusion Market, significant developments include advancements in technology and increased collaboration among key players such as TransMedics, Organ Recovery Systems, and Xvivo Perfusion. These companies are focusing on enhancing perfusion techniques to improve organ viability and transplant outcomes, impacting the overall market growth. The surge in investments has been noted, particularly by Vascular Insights and Fluent Medical, which are channeling resources into research and development to innovate their products and enhance operational efficiency. In recent news, SurgiCor and InnovaHealth have reported strategic partnerships aiming to expand their market presence and enhance service delivery in the field of organ preservation. Additionally, mergers and acquisitions have been a trend, with both CVS Medical and LifePort exploring collaborative opportunities to strengthen their market share. The overall market valuation is witnessing growth due to rising awareness about organ preservation and the increasing number of transplant surgeries, benefitting companies like Osmotica Pharmaceuticals and DBA Medical, which are actively involved in developing more efficient perfusion systems. ## **Normothermic Machine Perfusion Market Segmentation Insights** ### **Normothermic Machine Perfusion Market Application Outlook** ### **Normothermic Machine Perfusion Market End User Outlook** ### **Normothermic Machine Perfusion Market Product Type Outlook** ### **Normothermic Machine Perfusion Market Technology Outlook** ### **Normothermic Machine Perfusion Market Regional Outlook** ## Market Drivers ### 监管支持和指南 常温机灌注市场受益于监管支持的增加以及促进先进器官保存技术使用的指南的建立。监管机构正在认识到常温机灌注在改善移植结果方面的重要性，这导致了促进其采用的框架的发展。这种支持对希望实施这些技术的医疗机构至关重要，因为它提供了合规和报销的明确路径。此外，随着更多研究验证常温机灌注的有效性，预计监管认可将增加，进一步推动常温机灌注市场的增长。 ### 器官移植需求上升 慢性疾病和老龄化人口的日益普遍，导致对器官移植的需求加大，从而推动了常温机器灌注市场的发展。随着越来越多的患者需要器官移植，有效的保存方法变得至关重要。常温机器灌注通过在生理温度下维持器官，从而增强其在运输过程中的存活能力，提供了一个有前景的解决方案。市场数据显示，器官移植手术的数量稳步上升，肾脏和肝脏移植的显著增加尤为明显。这一日益增长的需求可能会推动常温机器灌注市场的发展，因为医疗服务提供者寻求可靠的方法以确保器官的质量和可用性。 ### 协作研究与开发工作 学术机构、医疗服务提供者和行业利益相关者之间的合作研究倡议在推动常温机器灌注市场方面发挥着关键作用。这些合作关系专注于探索新方法和改善与器官保存相关的现有技术。通过整合资源和专业知识，利益相关者可能会加速开发创新解决方案，从而提高器官的存活率。最近的合作导致了灌注技术的突破，这可能会显著影响移植成功率。随着这些研究工作的持续推进，常温机器灌注市场预计将受益于新技术和新实践的稳定涌入。 ### 灌注系统中的技术进步 常温机灌注市场正在经历技术进步的激增，这些进步提高了器官保存的效率和有效性。正在开发的创新技术，如改进的灌注溶液和自动监测系统，使得对器官活力的评估更加准确。这些进展可能会提高器官移植的成功率，从而推动市场需求。根据最近的数据，先进灌注设备的引入有可能显著改善器官保存时间，这可能导致更多成功的移植手术。随着技术的不断发展，常温机灌注市场预计将扩展，吸引投资并促进进一步的研究。 ### 医疗专业人员的意识不断提高 医疗专业人员对常温机器灌注的好处的认识显著提高，这对常温机器灌注市场产生了积极影响。正在组织教育项目和研讨会，以告知医务人员这种技术在器官保存中的优势。随着医疗提供者对常温机器灌注改善移植结果的潜力了解得越来越多，他们更有可能在临床环境中倡导其使用。这种日益增长的意识预计将导致常温机器灌注技术的更高采用率，从而推动常温机器灌注市场的整体增长。 ## Future Outlook 常温机灌注市场预计将在2024年至2035年间以18.07%的年复合增长率增长，推动因素包括技术进步、器官移植需求增加以及患者结果改善。 **New opportunities:** - 便携式灌注设备的开发，用于远程手术。 - 与医院合作提供综合灌注服务。 - 投资于基于人工智能的监测系统，以增强灌注管理。 到2035年，市场预计将强劲，反映出显著的增长和创新。 ## Segment Insights ### 按应用：器官保存（最大）与器官移植（增长最快） 在常温机器灌注市场中，应用细分反映出多样化的格局，器官保存作为主导力量脱颖而出。器官保存占据了市场的显著份额，因为它在增强器官移植前的生存能力方面发挥着关键作用。紧随其后的是器官移植本身，由于移植率的增加和外科技术的提升，器官移植在这一市场细分中成为了强有力的竞争者。 这一细分市场的增长趋势主要受到技术进步和对可用器官需求不断上升的推动。器官保存技术不断发展，为移植受者带来了更好的结果，并促进了器官的更长寿命。器官移植正经历快速增长，受益于捐赠者计划的扩展和对器官捐赠意识的提高，使其成为投资和研究的关键领域，代表了市场的一个重要细分。 器官保存（主导）与研发（新兴） 常温机器灌注市场中的应用领域明显区分为器官保存和研究与开发。器官保存被确立为主导框架，专注于在移植前阶段维持器官功能，这显著有助于减少器官损伤并提高移植结果。另一方面，研究与开发作为一种新兴力量，旨在创新和完善灌注技术。该领域致力于探索可以进一步提升器官保存和移植能力的新方法和产品，强调临床实践和治疗应用中持续改进的重要性。 ### 按最终用户：医院（最大）与研究实验室（增长最快） 在常温机器灌注市场中，医院部门占据了最大的市场份额，这得益于移植手术数量的增加和机器灌注技术的进步。尽管研究实验室的市场份额较小，但它们正在迅速增长，因为它们在器官保存和移植技术方面进行创新和改进，以满足该领域日益增长的研究活动需求。器官采购组织也发挥着至关重要的作用，尽管它们代表了一个重要但不那么主导的市场份额。 最终用户：医院（主导）与研究实验室（新兴） 医院目前是常温机器灌注市场的主要终端用户，利用先进技术进行器官存储和移植。他们受益于稳定的患者流，需求器官移植，使他们在维持和提升灌注实践中至关重要。研究实验室被归类为新兴参与者，通过参与与器官保存技术相关的创新研究，对市场做出了重要贡献。这包括增强器官安全运输和存活性的新方法，从而满足日益增长的科学兴趣和对改进器官保存方法的需求。 ### 按产品类型：便携式常温机（最大）与固定式常温机（增长最快） 在常温机灌注市场中，市场份额的分布显著倾向于便携式常温机，这些设备已成为医疗机构的主流选择。这些便携式设备因其灵活性和易用性而受到医院和救护服务的青睐。虽然固定式机器在市场中占有较小的份额，但它们在高容量应用中至关重要，特别是在需要持续和可靠机器性能的大型外科中心和医院中。 产品类型：便携式常温机（主导）与固定式常温机（新兴） 便携式常温机因其多功能性而受到认可，便于在各种环境中运输和使用，包括偏远地区和患者转运期间。它们通常配备用户友好的界面和轻便的设计，促进在关键情况下的快速部署。相比之下，固定式常温机则设计用于医院环境中的深入程序，专注于提供高效灌注所需的先进功能。它们被视为新兴创新，提供尖端技术，使其在需要高精度和可靠性的外科手术中越来越具吸引力。 ### 按技术分类：机械循环技术（最大）与氧合技术（增长最快） 在常温机器灌注市场中，机械循环技术占据了重要份额，因其在器官保存中的既定效用和有效性而引领该细分市场。这项技术已成为许多移植程序中的标准，使得更多的器官能够成功维持用于移植。相比之下，氧合技术虽然目前市场份额较小，但正在迅速获得关注。其在增强器官活力和减少储存期间损伤方面的创新能力使其成为一个关键的增长领域。 技术：机械循环技术（主导）与氧合技术（新兴） 机械循环技术在常温机器灌注市场中占据主导地位，其特点是能够在生理条件下维持器官灌注，显著改善整体移植结果。这项技术以其可靠性和稳健性而受到认可，常用于复杂病例。另一方面，氧合技术被视为一个新兴领域，具有革命性器官保存技术的潜力。通过有效增强器官的氧气输送，它旨在减轻缺血并确保更好的移植后功能，吸引寻求尖端解决方案的医疗服务提供者。 ## Regional Market Share Analysis ### 北美：引领创新与采用 北美是常温机器灌注市场最大的市场，约占全球市场份额的60%。该地区的增长受到先进医疗基础设施、器官移植率上升和支持性监管框架的推动。对创新器官保存技术的需求正在上升，这得益于对移植益处的日益认识和改善的患者结果。 美国是主要贡献者，主要参与者如器官回收系统和TransMedics在市场中处于领先地位。竞争格局的特点是对研发的重大投资以及医疗服务提供者与技术公司之间的合作。加拿大也发挥着重要作用，专注于提升器官捐献和移植过程，进一步巩固北美在该市场的地位。 ### 欧洲：具有增长潜力的新兴市场 欧洲是常温机器灌注市场第二大市场，约占全球市场份额的25%。该地区的增长受到器官移植程序增加、医疗技术进步和卫生当局支持性法规的推动。德国和英国等国处于前沿，开展旨在改善器官捐献率和移植结果的举措。 德国在市场中处于领先地位，得益于强大的医疗系统和对医学研究的重大投资。竞争格局中有关键参与者如Xvivo Perfusion和Bridge to Life，他们积极与医院和研究机构合作。欧盟关于器官移植的法规进一步促进了市场增长，确保了程序的安全性和有效性。“欧洲委员会强调创新技术在器官移植中改善患者结果的重要性，”欧洲委员会。 ### 亚太地区：快速增长的市场动态 亚太地区在常温机器灌注市场中正经历快速增长，约占全球市场份额的10%。该地区的扩展受到医疗投资增加、器官捐献意识提升和医疗基础设施改善的推动。中国和日本等国正在引领潮流，专注于提升器官移植能力和患者护理。 中国正在成为一个重要参与者，政府举措旨在提高器官捐献率和改善移植技术。竞争格局正在演变，本地和国际公司争夺市场份额。医疗服务提供者与技术公司之间的合作变得越来越普遍，促进了创新并改善了患者结果。随着越来越多的国家认识到先进器官保存技术的重要性，该地区的增长潜力是巨大的。 ### 中东和非洲：未开发的市场机会 中东和非洲地区在常温机器灌注市场中仍在发展，约占全球市场份额的5%。增长受到医疗投资增加、器官移植意识提升和政府旨在改善医疗基础设施的举措的推动。南非和阿联酋等国在提升器官捐献和移植过程方面取得了进展。 南非在市场中处于领先地位，得益于不断增加的移植中心数量和与国际组织的合作。竞争格局的特点是新兴本地参与者和与全球公司的合作。随着该地区继续投资于医疗进步，对创新器官保存技术的需求预计将上升，为增长提供显著机会。 ## Competitive Benchmarking 全球常温机器灌注市场正在经历显著的演变，受到医疗技术进步和器官移植需求增加的推动。竞争格局由多样化的参与者构成，所有参与者都在追求创新解决方案，以改善器官保存和提升手术结果。 主要竞争者专注于研发工作，以将先进的灌注技术推向市场，确保其产品在器官移植的效率和有效性方面始终处于前沿。随着市场的持续扩展，重点不仅在于产品创新，还在于建立战略合作伙伴关系和协作，以增强市场存在感并更广泛地接触全球医疗服务提供者。 SurgiCor已在全球常温机器灌注市场中确立了显著的地位，利用其强大的技术能力和对质量的承诺。该公司以其强大的产品组合而闻名，旨在提供最佳的器官保存解决方案，与外科实践无缝集成。 其对客户关系的重视和对临床医生需求的理解使SurgiCor能够在医疗服务提供者中培养忠诚度。强大的研发举措使SurgiCor能够始终走在前沿，不断推出增强器官灌注有效性的尖端解决方案。 该公司对合规性和临床验证的专注进一步增强了其在市场上的品牌声誉。 InnovaHealth在全球常温机器灌注市场中采取了独特的方法，旨在创新满足特定临床需求的器官保存技术。该公司因其灵活的开发策略和对市场需求的响应而受到认可，使其能够迅速调整产品供应。 InnovaHealth的优势在于与关键利益相关者（包括医院和移植中心）的合作，确保其解决方案不仅有效，而且满足医疗专业人员的实际需求。该公司采用以客户为中心的方法，专注于通过量身定制的解决方案提供卓越价值，从而增强器官的生存能力。 因此，InnovaHealth能够在市场上建立显著的存在感，其特点是通过战略合作伙伴关系增强其声誉并扩大其在器官移植领域的影响力。 ## Recent News & Developments 在全球常温机器灌注市场，重要的发展包括技术的进步和关键参与者之间的合作增加，如TransMedics、Organ Recovery Systems和Xvivo Perfusion。这些公司专注于提升灌注技术，以改善器官的存活率和移植结果，从而影响整体市场增长。 投资的激增已被注意到，特别是Vascular Insights和Fluent Medical，它们正在将资源投入到研究和开发中，以创新其产品并提高运营效率。 最近的消息中，SurgiCor和InnovaHealth报告了战略合作伙伴关系，旨在扩大其市场存在并提升器官保存领域的服务交付。 此外，合并和收购已成为一种趋势，CVS Medical和LifePort都在探索合作机会，以增强其市场份额。 由于对器官保存的认识提高以及移植手术数量的增加，整体市场估值正在增长，这使得Osmotica Pharmaceuticals和DBA Medical等公司受益，它们积极参与开发更高效的灌注系统。 ## Report Scope | 2024年市场规模 | 16.3（十亿美元） | | --- | --- | | 2025年市场规模 | 19.24（十亿美元） | | 2035年市场规模 | 101.3（十亿美元） | | 复合年增长率（CAGR） | 18.07%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 十亿美元 | | 主要公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 主要市场机会 | 器官保存技术的进步增强了常温机器灌注市场的可行性。 | | 主要市场动态 | 器官移植需求的上升推动了常温机器灌注市场的创新和竞争。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: What is the projected market valuation of the Normothermic Machine Perfusion Market by 2035?** A: The market is projected to reach a valuation of 10.13 USD Billion by 2035. **Q: What was the market valuation of the Normothermic Machine Perfusion Market in 2024?** A: The market valuation was 1.63 USD Billion in 2024. **Q: 在2025年至2035年的预测期内，常温机灌注市场的预期CAGR是多少？** A: The expected CAGR for the market during this period is 18.07%. **Q: 在常温机灌注市场中，预计哪个应用领域将实现最高增长？** A: 器官移植领域预计到2035年将从8.1亿美元增长至50.6亿美元。 **Q: 常温机灌注市场的关键参与者有哪些？** A: 主要参与者包括器官恢复系统、TransMedics、Xvivo Perfusion 和 LifePort 等。 **Q: 便携式常温机 segment 在市场规模方面与固定式常温机 segment 相比如何？** A: 可携式常温机 segment 预计将从 0.65 增长到 3.9 亿美元，而固定式 segment 预计将从 0.98 增长到 6.23 亿美元。 **Q: 在常温机灌注市场中，作为最终用户的研究实验室预期市场规模是多少？** A: 研究实验室的市场规模预计将从4.5亿美元增长到25亿美元，到2035年。 **Q: Which technology segment is expected to show significant growth in the Normothermic Machine Perfusion Market?** A: 机械循环技术部门预计到2035年将从6.5亿美元增长到39.5亿美元。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/normothermic-machine-perfusion-market-40190*